<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="rapid-communication" xml:lang="en">
	<front>
		<journal-meta>
			<journal-id journal-id-type="publisher-id">AJMB</journal-id>
			<journal-title>Avicenna Journal of Medical Biotechnology</journal-title>
			<issn pub-type="ppub">2008-2835</issn>
			<issn pub-type="epub">2008-4625</issn>
			<publisher>
				<publisher-name>Avicenna Research Institute</publisher-name>
			</publisher>
		</journal-meta>
		<article-meta>
			<article-id pub-id-type="publisher-id">AJMB-4-206</article-id>
			<article-categories>
				<subj-group subj-group-type="heading">
					<subject>Short Communication</subject>
				</subj-group>
			</article-categories>
			<title-group>
				<article-title>Amplification of GC-rich Putative Mouse PeP Promoter using Betaine and DMSO in Ammonium Sulfate Polymerase Chain Reaction Buffer</article-title>
			</title-group>
			<contrib-group>
				<contrib contrib-type="author">
					<name>
						<surname>Seifi</surname>
						<given-names>Tahere</given-names>
					</name>
					<xref ref-type="aff" rid="AF0001">1</xref>
				</contrib>
				<contrib contrib-type="author" corresp="yes">
					<name>
						<surname>Ghaedi</surname>
						<given-names>Kamran</given-names>
					</name>
					<xref ref-type="aff" rid="AF0001">1</xref>
					<xref ref-type="aff" rid="AF0002">2</xref>
					<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Salamian</surname>
						<given-names>Ahmad</given-names>
					</name>
					<xref ref-type="aff" rid="AF0002">2</xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Tanhaei</surname>
						<given-names>Sommayeh</given-names>
					</name>
					<xref ref-type="aff" rid="AF0002">2</xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Safari</surname>
						<given-names>Forouzan</given-names>
					</name>
					<xref ref-type="aff" rid="AF0001">1</xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Hojati</surname>
						<given-names>Zohreh</given-names>
					</name>
					<xref ref-type="aff" rid="AF0001">1</xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Tavassoli</surname>
						<given-names>Manuchehr</given-names>
					</name>
					<xref ref-type="aff" rid="AF0001">1</xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Baharvand</surname>
						<given-names>Hossein</given-names>
					</name>
					<xref ref-type="aff" rid="AF0003">3</xref>
					<xref ref-type="aff" rid="AF0004">4</xref>
				</contrib>
				<contrib contrib-type="author" corresp="yes">
					<name>
						<surname>Esfahani</surname>
						<given-names>Mohammad-Hossein Nasr</given-names>
					</name>
					<xref ref-type="aff" rid="AF0002">2</xref>
					<xref ref-type="corresp" rid="cor2">&#x002A;</xref>
				</contrib>
			</contrib-group>
			<aff id="AF0001">
				<label>1</label>Department of Biology, School of Sciences, University of Isfahan, Isfahan, Iran</aff>
			<aff id="AF0002">
				<label>2</label>Department of Cell and Molecular Biology, Cell Science Research Center, Royan Institute for Animal Biotechnology, ACECR, Isfahan, Iran</aff>
			<aff id="AF0003">
				<label>3</label>Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran</aff>
			<aff id="AF0004">
				<label>4</label>Department of Developmental Biology, University of Science and Culture, ACECR, Tehran, Iran</aff>
			<author-notes>
				<corresp id="cor1">
					<label>&#x002A;</label>
					<bold>Corresponding author:</bold> Kamran Ghaedi, Ph.D., Department of Cell and Molecular Biology, Cell Science Research Center, Royan Institute for Animal Biotechnology, ACECR, Isfahan, Iran. <bold>Tel:</bold> +98 311 2612900. <bold>Fax:</bold> +98 311 2605525. <bold>E-mail:</bold>
					<email xlink:href="kamranghaedi@royaninstitute.org">kamranghaedi@royaninstitute.org</email></corresp>
				<corresp id="cor2">
					<label>&#x002A;</label>
					<bold>Corresponding author:</bold> Mohammad Hossein Nasr Esfahani, Ph.D., Department of Cell and Molecular Biology, Cell Science Research Center, Royan Institute for Animal Biotechnology, ACECR, Isfahan, Iran. <bold>Tel:</bold> +98 311 2612900. <bold>Fax:</bold> +98 311 2605525. <bold>E-mail:</bold>
					<email xlink:href="mh.nasr-esfahani@royaninstitute.org">mh.nasr-esfahani@royaninstitute.org</email>
				</corresp>
			</author-notes>
			<pub-date pub-type="ppub">
				<season>October-December</season>
				<year>2012</year>
			</pub-date>
			<volume>4</volume>
			<issue>4</issue>
			<fpage>206</fpage>
			<lpage>209</lpage>
			<history>
				<date date-type="received">
					<day>22</day>
					<month>04</month>
					<year>2012</year>
				</date>
				<date date-type="accepted">
					<day>16</day>
					<month>07</month>
					<year>2012</year>
				</date>
			</history>
			<permissions>
				<copyright-statement>Copyright &#x00A9; 2012 Avicenna Research Institute</copyright-statement>
				<copyright-year>2012</copyright-year>
				<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
					<p>This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.</p>
				</license>
			</permissions>
			<abstract>
				<sec id="st1">
					<title>Background</title>
					<p>Recently, we have shown that peroxisomal protein expression was induced upon retinoic acid treatment in mouse embryonic stem cells during the process of neurogenesis. Thus, characterization of the respective promoter could elucidate the molecular aspects of transcriptional regulation of this gene.</p>
				</sec>
				<sec id="st2">
					<title>Methods</title>
					<p>Using the conventional software programs for promoter prediction, a putative promoter region was identified approximately 561 <italic>bp</italic> upstream of the peroxisomal protein coding sequence. In order to clone this region with a GC-content of 71.01%, a cocktail of ammonium sulfate buffer supplied with two additive components, betaine and dimethyl sulfoxide, and a high concentration of MgCl<sub>2</sub> was used.</p>
				</sec>
				<sec id="st3">
					<title>Results</title>
					<p>The modulated polymerase chain reaction composition significantly improved the amplification of GC-rich DNA target sequences. Improved amplification of this region was due to reduction in the formation of secondary structures by the GC-rich region.</p>
				</sec>
				<sec id="st4">
					<title>Conclusion</title>
					<p>Therefore, this polymerase chain reaction composition could be generally used to facilitate the amplification of other GC-rich DNA sequences as verified by amplification of different GC rich regions.</p>
				</sec>
			</abstract>
			<kwd-group>
				<kwd>Amplification</kwd>
				<kwd>GC-rich region</kwd>
				<kwd>Peroxsiomal protein</kwd>
				<kwd>Promoter</kwd>
			</kwd-group>
		</article-meta>
	</front>
	<body>
		<sec id="S0001" sec-type="intro">
			<title>Introduction</title>
			<p>Polymerase Chain Reaction (PCR) is a conventional method for amplification of DNA regions while templates with high percentages of GC bases including eukaryotic promoter regions are not easily amplified (<xref ref-type="bibr" rid="CIT0001">1</xref>&#x2013;<xref ref-type="bibr" rid="CIT0004">4</xref>). In this state, PCR results in production of undesired truncated fragments instead of bona fide product (<xref ref-type="bibr" rid="CIT0001">1</xref>, <xref ref-type="bibr" rid="CIT0005">5</xref>).</p>
			<p>Several approaches have been proposed to overcome this problem including additives usage in different PCR procedures (<xref ref-type="bibr" rid="CIT0002">2</xref>, <xref ref-type="bibr" rid="CIT0006">6</xref>). Different additives were utilized to amplify GC-rich regions including betaine (N,N,N- trimethylglycin), dimethyl sulfoxide (DMSO), formamide, glycerin, glycerol, dithiothreitol (DTT), Bovine Serum Albumin (BSA), non-ionic detergents such as Triton X-100, nucleotide analogs 7-deaza dGTP, ethylene glycol and 1, 2-propanediol, and reducing agents such as &#x3B2;-mercapto-ethanol (<xref ref-type="bibr" rid="CIT0001">1</xref>&#x2013;<xref ref-type="bibr" rid="CIT0009">9</xref>). These additives not only prevent secondary structure formation of both templates and primers, but also increase the annealing chance of primers to plate strands at temperatures lower than the melting temperature of primers (<xref ref-type="bibr" rid="CIT0001">1</xref>, <xref ref-type="bibr" rid="CIT0003">3</xref>, <xref ref-type="bibr" rid="CIT0005">5</xref>, <xref ref-type="bibr" rid="CIT0007">7</xref>, <xref ref-type="bibr" rid="CIT0009">9</xref>).</p>
			<p>In the present study, we have utilized a combination of betaine and DMSO to amplify the putative promoter region of mouse peroxisomal protein (PeP). Mouse PeP which has been identified as a fibronectin type III domain containing protein (FNDC5; NCBI accession no: NC_000070) is supposed to undergo proteolytic cleavage and releasing to the extracellular space (<xref ref-type="bibr" rid="CIT0010">10</xref>, <xref ref-type="bibr" rid="CIT0011">11</xref>). Our data have elucidated that its expression increased upon Retinoic Acid (RA) treatment during the process of neurogenesis (<xref ref-type="bibr" rid="CIT0012">12</xref>).</p>
			<p>Very recently Bostrom <italic>et al</italic> have indicated that the cleaved form of PeP named irisin is a secreting myokine which its production could be induced after exercise, may improve the glucose homeostasis by regulating the obesity (<xref ref-type="bibr" rid="CIT0011">11</xref>). To find out molecular mechanisms involved in the regulation of PeP expression, a putative promoter region at position -561/+101 relative to the Transcription Start Site (TSS), upstream of the PeP gene was chosen for amplification and further cloning.</p>
		</sec>
		<sec id="S0002" sec-type="materials|methods">
			<title>Materials and Methods</title>
			<p>To predict a potential promoter region of mouse PeP (Accession No: NC_000070), approximately 2x10<sup>4</sup> <italic>bp</italic> upstream of the PeP gene was submitted to the Geno-matix (<ext-link ext-link-type="uri" xlink:href="http://www.Geno-matix.de/en/index.html">http://www.Geno-matix.de/en/index.html</ext-link>) (<xref ref-type="bibr" rid="CIT0013">13</xref>) and Proscan (<ext-link ext-link-type="uri" xlink:href="http://www.proscan.co.za/">http://www.proscan.co.za/</ext-link>) (Version 1.7) software programs. DNA extraction was performed on i) one Caucasian individual after signing a consent form and ii) a heart tissue sample of NMRI mouse, which was obtained from Royan Institute (Tehran, Iran) using DNeasy Blood and Tissue Kit (Qiagen, Germany). The ethics approval to use specimen was obtained from Royan Institute Bioethics Committee (Approval ID. No: EC-90-1077). Then 857 <italic>bp</italic> upstream of the PeP gene including a part of the transcriptional region was chosen for amplification using specific primers in conventional PCR (<xref ref-type="table" rid="T0001">Table 1</xref>). Then, a set of PCRs was performed to identify the optimal amplification conditions using betaine (Sigma), DMSO (Merck), glycerol (Merck), formamide (Scharlau), DTT (Sigma) (<xref ref-type="bibr" rid="CIT0001">1</xref>&#x2013;<xref ref-type="bibr" rid="CIT0009">9</xref>). Moreover, different approaches of PCR including touch-down PCR (<xref ref-type="bibr" rid="CIT0002">2</xref>, <xref ref-type="bibr" rid="CIT0006">6</xref>), slow-down PCR (<xref ref-type="bibr" rid="CIT0002">2</xref>) and hot-start PCR were applied. Finally, the successful amplification condition for amplicon (875 <italic>bp</italic>), included 10x PCR buffer AMS [composed of 750 <italic>mM</italic> of tris-HCl (pH = 8.8), 200 <italic>mM</italic> of (NH<sub>4</sub>)<sub>2</sub>SO<sub>4</sub>, 0.1% Tween 20] (Cinna-Gen, Iran) and 4 <italic>mM</italic> Mg<sup>2+</sup> (Cinnagen, Iran). To improve PCR efficiency, different concentrations of betaine (0.5 to 1 <italic>M</italic>) and DMSO (5-10% <italic>v/v</italic>) were applied. Simultaneously, similar amplification condition was repeated in <italic>Pfu</italic> buffer [200 <italic>mM</italic> of Tris-HCl (pH = 8.8), 100 <italic>mM</italic> of KCl, 100 <italic>mM</italic> of (NH<sub>4</sub>)<sub>2</sub>SO<sub>4</sub>, 1% Triton X-100 and 1 <italic>mg/ml</italic> of nuclease-free BSA] (Fermentas, Lithuania) instead of 10 x PCR buffer AMS. Touch-down PCR was carried out in an Eppendorf thermocycler (Eppendorf, Germany) with one step of initial denaturation at 95<italic>&#x00B0;C</italic> for 5 <italic>min</italic> followed by twenty repetitive cycles, including 94<italic>&#x00B0;C</italic> for 10 <italic>s</italic>, a variable annealing step and an elongation step at 72<italic>&#x00B0;C</italic> for 4 <italic>min</italic>. The variable annealing step was started at a temperature of 66<italic>&#x00B0;C</italic> which decreased by 0.5<italic>&#x00B0;C</italic>/ cycle to reach a temperature of 56 <italic>&#x00B0;C</italic> for 30 <italic>s</italic>. Subsequently, additional amplification was continued for 20 cycles with a constant annealing temperature of 56<italic>&#x00B0;C</italic> for 30 <italic>s</italic>. PCR was terminated after final elongation step at 72<italic>&#x00B0;C</italic> for 10 <italic>min</italic>.
</p>
			<table-wrap id="T0001">
				<label>Table 1</label>
				<caption>
					<p>Primers used for amplification of nucleotides</p>
				</caption>
				<table frame="hsides" rules="groups">
					<thead>
						<tr>
							<th align="left">Amplified DNA (species)</th>
							<th align="center">Primers sequence</th>
							<th align="center">Length of product</th>
							<th align="center">Product GC%</th>
							<th align="center">Accession No.</th>
						</tr>
					</thead>
					<tbody>
						<tr>
							<td align="left" valign="middle">
								<bold>PeP Promoter (Mouse)</bold>
							</td>
							<td align="center">F: 5&#x0027; GCT <underline>ATT AAT</underline> GAA AGG ACT GGT CTG AGG TCT CAG 3&#x0027;<break/>R: 5&#x0027; GTT <underline>GCT AGC</underline> CTA GGG TCA GGT TAG GAG AGT AGG 3&#x0027;</td>
							<td align="center" valign="middle">875 <italic>bp</italic>
							</td>
							<td align="center" valign="middle">70.01%</td>
							<td align="center" valign="middle">NC_000070</td>
						</tr>
						<tr>
							<td align="left" valign="middle">
								<bold>Androgen receptor (Exon I) (Human)</bold>
							</td>
							<td align="center">F: 5&#x0027; ACC CTC AGC CGC CGC TTC CTC ATC 3&#x0027;<break/>R: 5&#x0027; CTG GGA TAG GGC ACT CTG CTC ACC 3&#x0027;</td>
							<td align="center" valign="middle">270 <italic>bp</italic>
							</td>
							<td align="center" valign="middle">71.80%</td>
							<td align="center" valign="middle">NC_000023</td>
						</tr>
						<tr>
							<td align="left" valign="middle">
								<bold>Eukaryotic releasing factor 3a (Exon I) (Human)</bold>
							</td>
							<td align="center">F: 5&#x0027; CAT TTC TCG CTC TCT GTC CAC 3&#x0027;<break/>R: 5&#x0027; CTG GTC CCA GCA GTC AGG 3&#x0027;</td>
							<td align="center" valign="middle">142 <italic>bp</italic>
							</td>
							<td align="center" valign="middle">75.94%</td>
							<td align="center" valign="middle">NC_000016</td>
						</tr>
						<tr>
							<td align="left" valign="middle">
								<bold>Elongation factor 1a promoter (Human)</bold>
							</td>
							<td align="center">F: 5&#x0027; GTT <underline>ATT AAT</underline> CGT GAG GCT CCG GT3&#x0027;<break/>R: 5&#x0027; GCC <underline>GCT AGC</underline> TCA CGA CAC CTG AA3&#x0027;</td>
							<td align="center" valign="middle">1186 <italic>bp</italic>
							</td>
							<td align="center" valign="middle">60.09%</td>
							<td align="center" valign="middle">NC_000020</td>
						</tr>
					</tbody>
				</table>
				<table-wrap-foot>
					<fn>
						<p>F and R, are referred as forward and reverse primers respectively. <italic>Ase</italic>I (ATTAAT) and <italic>Nhe</italic>I (GCTAGC) restriction sites are underlined</p>
					</fn>
				</table-wrap-foot>
			</table-wrap>
			<p>To demonstrate whether optimized PCR condition was applicable for other GC enriched regions, similar procedure was repeated for amplification of different loci on human genome (<xref ref-type="table" rid="T0001">Table 1</xref>). Secondary structures predictions of the putative promoter of PeP and other amplified loci were assessed by Mfold web server (<ext-link ext-link-type="uri" xlink:href="http://mfold.Bio-info.rpi.edu/">http://mfold.Bio-info.rpi.edu/</ext-link>) (<xref ref-type="bibr" rid="CIT0014">14</xref>).</p>
		</sec>
		<sec id="S0003" sec-type="results">
			<title>Results</title>
			<sec id="S20004">
				<title>Putative promoter prediction and amplification</title>
				<p>Computational analyses predicted a putative promoter region in location of -561 to +101 relative to the TSS of PeP gene (<xref ref-type="fig" rid="F0001">Figure 1A</xref>) with high GC content (approximately 71.01%) (<xref ref-type="fig" rid="F0001">Figure 1B</xref>). Secondary structure prediction of this region indicated formation of nine independent structures owing to its high internal energy in the range of -199.73 to -209.77 <italic>kcal/mol</italic> (data not shown). Two extreme structures with the highest and the lowest internal energy are shown in <xref ref-type="fig" rid="F0001">Figure 1C</xref>. Cloning of this region was carried out using different PCRs to obtain proper amplification. However, there were no product yields regardless of different additives (<xref ref-type="fig" rid="F0002">Figure 2A</xref>). Data indicated utilization of a mixture containing 10x PCR buffer AMS with different amounts of betaine (final: 0.5, 0.75 and 1 <italic>M</italic>), and 5-10% (<italic>v/v</italic>) of DMSO improved PCR yield (<xref ref-type="fig" rid="F0002">Figure 2B</xref>, lanes 5-7). Meanwhile, substitution of <italic>Pfu</italic> buffer with 5% (<italic>v/v</italic>) DMSO in the PCR reaction resulted in amplification of desired fragment (<xref ref-type="fig" rid="F0002">Figure 2C</xref>, lane 2).</p>
				<fig id="F0001">
					<label>Figure 1</label>
					<caption>
						<p>DNA sequence, GC and CpG nucleotide composition graph of the putative promoter of PeP gene. A) Sequence of DNA fragment consisting of PeP gene (Accession no: NC_000070) putative promoter. The initiation codon is underlined. B) Genetyx software was used to plot the GC-graph and CpG plot programs (<ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/Tools/es/cgi-bin/jobresults.cgi/cpgplot/cpgplot-20100823-1343338151.html">http://www.ebi.ac.uk/Tools/es/cgi-bin/jobresults.cgi/cpgplot/cpgplot-20100823-1343338151.html</ext-link>). Translation start site (TSS) is located at position +21 relative to the transcription start site. Primer sequences are shown below the graph. C) Two different secondary structures predicted graphs of target DNA based on the Mfold web server (<ext-link ext-link-type="uri" xlink:href="http://mfold.bioinfo.rpi.edu/">http://mfold.bioinfo.rpi.edu/</ext-link>) for nucleic acid folding and hybridization prediction as noted in the Materials and Methods section. The internal energy required for formation of these constructs is indicated as <italic>kcal/mole</italic>
						</p>
					</caption>
					<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="AJMB-4-206-g001.tif" alt-version="no"/>
				</fig>
				<fig id="F0002">
					<label>Figure 2</label>
					<caption>
						<p>Effects of additives and PCR buffers on amplification of the putative promoter of PeP gene. Betaine (0-1 <italic>M</italic>) and DMSO (0-10% <italic>v/v</italic>) (lanes 2-8) were added to the different PCR reaction buffers to obtain amplification of the putative promoter region of the PeP gene. The desired PCR products (875 <italic>bp</italic>) are indicated by arrow heads while the star represents the nonspecifc band. Lane one represents the DNA ladder (100 <italic>bp</italic>)</p>
					</caption>
					<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="AJMB-4-206-g002.tif" alt-version="no"/>
				</fig>
			</sec>
			<sec id="S20005">
				<title>Improvement of the PCR yield</title>
				<p>Interestingly increased amounts of MgCl<sub>2</sub> (3 and 4 <italic>mM</italic>) improved PCR yields. Particularly, PCR buffer AMS supplied with DMSO (10% <italic>v/v</italic>), betaine (final concentration: 1 <italic>M</italic>) and 4 <italic>mM</italic> of MgCl<sub>2</sub> improved PCR efficiency (<xref ref-type="fig" rid="F0003">Figure 3</xref>). While, utilization of touch down PCR did not enhance the PCR product amounts compared to the conventional PCR approach (<xref ref-type="fig" rid="F0004">Figure 4</xref>).</p>
				<fig id="F0003">
					<label>Figure 3</label>
					<caption>
						<p>Optimization of amplification of the <italic>PeP</italic> gene putative promoter region by increasing MgCl<sub>2</sub>. The same PCR conditions of <xref ref-type="fig" rid="F0002">figures 2B</xref> (lanes 5-7) and 2C (lanes 2 and 5) were repeated using 3 and 4 <italic>mM</italic> MgCl<sub>2</sub>, respectively (A, B)</p>
					</caption>
					<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="AJMB-4-206-g003.tif" alt-version="no"/>
				</fig>
				<fig id="F0004">
					<label>Figure 4</label>
					<caption>
						<p>Optimized condition for amplification of the GC-rich putative promoter of the mouse <italic>PeP</italic> gene by different PCRs. The amplification of the 875 <italic>bp</italic> fragment was carried out by conventional (A) and touch-down PCR (B) using the mentioned annealing temperatures (Ta) and PCR conditions as described for <xref ref-type="fig" rid="F0003">figure 3a</xref> (lane 4)</p>
					</caption>
					<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="AJMB-4-206-g004.tif" alt-version="no"/>
				</fig>
				<p>To verify the efficacy of our approach, Androgen Receptor (Exon 1) and Eukaryotic Releasing Factor 3a (Exon 1) genes from a human source and a portion of human Elongation Factor 1a Promoter encompassing 71.8, 75.94 and 60.09% GC bases respectively were chosen for amplification (<xref ref-type="table" rid="T0001">Table 1</xref>). The expected 270 <italic>bp</italic> PCR product band for exon 1 of human Androgen receptor was observed significantly when 5-10% DMSO, 0.5-0.75 <italic>M</italic> betaine was used in PCR buffer AMS or Pfu buffer (<xref ref-type="fig" rid="F0005">Figure 5A</xref>, left panel). Similarly, the amplified region of Eukaryotic Releasing Factor <italic>3a</italic> (142 <italic>bp</italic>) was visualized when 5-7.5% DMSO, 0.5-0.75<italic>M</italic> betaine in PCR buffer AMS reaction was used (<xref ref-type="fig" rid="F0005">Figure 5A</xref>, right panel). Moreover, amplification for promoter region of Elongation Factor 1a was achieved when 4 <italic>mM</italic> of MgCl<sub>2</sub> was added to the Pfu buffer (<xref ref-type="fig" rid="F0005">Figure 5A</xref>, middle panel and <xref ref-type="fig" rid="F0005">Figure 5B</xref>). Secondary structure prediction of aforementioned amplicons indicated formation of secondary structures due to presence of high internal energy (<xref ref-type="fig" rid="F0005">Figure 5C</xref>).</p>
				<fig id="F0005">
					<label>Figure 5</label>
					<caption>
						<p>A similar protocol comprising (NH<sub>4</sub>)<sub>2</sub>SO<sub>4</sub>, MgCl<sub>2</sub>, betaine and DMSO in PCR reaction was applied for efficient amplification of different loci in human genome. The same PCR reaction conditions of <xref ref-type="fig" rid="F0002">figure 2</xref> was fulfilled to amplify several regions from human Androgen receptor, Eukaryotic Releasing Factor 3a, and Elongation Factor 1a (A). The same PCR conditions of <xref ref-type="fig" rid="F0005">figure 5A</xref> (lanes 1) was repeated using 1.5-4<italic>mM</italic> MgCl<sub>2</sub> in Pfu buffer, to obtain a product band for Elongation Factor 1a with higher intensity (B). Two different predicted secondary structures graphs of target DNA as notified in <xref ref-type="fig" rid="F0001">figure 1</xref> were obtained for nucleic acid folding and hybridization prediction. The internal energy required for formation of these constructs is indicated as <italic>kcal/mole</italic>. Please note that in case of Eukaryotic Releasing Factor 3a, only one type of secondary structure was suggested by software</p>
					</caption>
					<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="AJMB-4-206-g005.tif" alt-version="no"/>
				</fig>
			</sec>
		</sec>
		<sec id="S0006" sec-type="discussion">
			<title>Discussion</title>
			<p>Amplification of GC-rich genomic regions requires time-consuming work to be optimized. Additives such as betaine (<xref ref-type="bibr" rid="CIT0001">1</xref>, <xref ref-type="bibr" rid="CIT0003">3</xref>, <xref ref-type="bibr" rid="CIT0005">5</xref>&#x2013;<xref ref-type="bibr" rid="CIT0009">9</xref>), DMSO (<xref ref-type="bibr" rid="CIT0001">1</xref>, <xref ref-type="bibr" rid="CIT0003">3</xref>, <xref ref-type="bibr" rid="CIT0005">5</xref>, <xref ref-type="bibr" rid="CIT0006">6</xref>, <xref ref-type="bibr" rid="CIT0008">8</xref>), form-amide (<xref ref-type="bibr" rid="CIT0001">1</xref>, <xref ref-type="bibr" rid="CIT0003">3</xref>), glycerol (<xref ref-type="bibr" rid="CIT0001">1</xref>, <xref ref-type="bibr" rid="CIT0006">6</xref>), glycerin (<xref ref-type="bibr" rid="CIT0007">7</xref>), BSA (<xref ref-type="bibr" rid="CIT0003">3</xref>), non-ionic detergents such as Triton X-100 (<xref ref-type="bibr" rid="CIT0001">1</xref>), nucleotide analogs 7-deaza dGTP (<xref ref-type="bibr" rid="CIT0005">5</xref>&#x2013;<xref ref-type="bibr" rid="CIT0007">7</xref>), DTT (<xref ref-type="bibr" rid="CIT0003">3</xref>), ethylene glycol (<xref ref-type="bibr" rid="CIT0009">9</xref>), 1,2-propanediol (<xref ref-type="bibr" rid="CIT0009">9</xref>), reducing compounds such as &#x3B2;-mercapto-ethanol (<xref ref-type="bibr" rid="CIT0003">3</xref>) and their combination have been utilized to optimize amplification. However, effects of these additives on amplification of different fragments are not similar (<xref ref-type="bibr" rid="CIT0009">9</xref>). For instance, betaine not only acts to reduce the DNA thermal melting transition dependent on base pair composition, but also does not allow DNA polymerase to pause near hairpin-loop structures (<xref ref-type="bibr" rid="CIT0007">7</xref>). Thus, a combination of betaine and DMSO make GC-rich fragments of DNA accessible for DNA polymerase (<xref ref-type="bibr" rid="CIT0007">7</xref>). However, in this research no efficient amplification was seen using both betaine and DMSO. Previous reports have indicated that amplification of 71%&#x003E; GC-rich DNA fragments was achieved by the addition of 16.6 <italic>mM</italic> (NH<sub>4</sub>)<sub>2</sub>SO<sub>4</sub>, 3.1 <italic>mM</italic> MgCl<sub>2</sub> and 0.01% Tween 20 (<xref ref-type="bibr" rid="CIT0003">3</xref>). In the present study, in order to amplify mouse PeP promoter with 71.01% GC, two different reaction buffers (10x PCR reaction buffer AMS and Pfu buffer) containing (NH<sub>4</sub>)<sub>2</sub>SO<sub>4</sub> were utilized. The application of these reaction buffers resulted in efficient amplification due to reduction in the formation of secondary structure due to GC-rich regions. Computational analysis confirmed that secondary structure formation of a putative region of mouse PeP promoter was highly possible. Previous studies have shown that proper concentration of Mg<sup>2+</sup> ion increased the productivity and fidelity of DNA polymerases due to the increased DNA/ DNA interactions and formation of complexes with dNTPs. However, higher amounts of MgCl<sub>2</sub> may inhibit polymerase activity (<xref ref-type="bibr" rid="CIT0015">15</xref>&#x2013;<xref ref-type="bibr" rid="CIT0017">17</xref>). In the present study, increased MgCl<sub>2</sub> concentration (4 <italic>mM</italic>) was efficient. In some instances, modifications of the PCR procedure including a touch-down PCR is needed to gain satisfactory PCR products. However, utilization of this procedure did not yield more product than the conventional PCR. Our data demonstrated that addition of (NH<sub>4</sub>)<sub>2</sub>SO<sub>4</sub> in PCR reaction with suitable concentrations of MgCl<sub>2</sub>, betaine and DMSO would yield the highest amount of several amplicons.</p>
		</sec>
	</body>
	<back>
		<ack>
			<title>Acknowledgement</title>
			<p>We thank Mr. Mohammad Hadi Sekhavati for his excellent technical assistance and helpful advice. This project was financed by a grant-in-aid of research from Royan Institute (Grant No. 148) to Kamran Ghaedi as the principal investigator and in support of Ms. Tahere Seifi for obtaining her MSc degree from the University of Isfahan.</p>
		</ack>
		<ref-list>
			<title>References</title>
			<ref id="CIT0001">
				<label>1</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Sahdev</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Saini</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Tiwari</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Sexena</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Saini</surname>
							<given-names>KS</given-names>
						</name>
					</person-group>
					<article-title>Amplification of GC-rich genes by following a combination strategy of primer design, enhancers and modified PCR cycle conditions</article-title>
					<source>Mol Cell Probs</source>
					<year>2007</year>
					<volume>21</volume>
					<issue>4</issue>
					<fpage>303</fpage>
					<lpage>307</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0002">
				<label>2</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Hube</surname>
							<given-names>F</given-names>
						</name>
						<name>
							<surname>Reverdiau</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Lochmann</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Gruel</surname>
							<given-names>Y</given-names>
						</name>
					</person-group>
					<article-title>Improved PCR method for amplification of GC-rich DNA sequences</article-title>
					<source>Mol Biotech</source>
					<year>2005</year>
					<volume>31</volume>
					<issue>1</issue>
					<fpage>81</fpage>
					<lpage>84</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0003">
				<label>3</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Ralser</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Querfurth</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>Warnatz</surname>
							<given-names>HJ</given-names>
						</name>
						<name>
							<surname>Lehrach</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Yaspo</surname>
							<given-names>ML</given-names>
						</name>
						<name>
							<surname>Krobitsch</surname>
							<given-names>S</given-names>
						</name>
					</person-group>
					<article-title>An efficient and economic enhancer mix for PCR</article-title>
					<source>Biochem Biophys Res Commun</source>
					<year>2006</year>
					<volume>347</volume>
					<issue>3</issue>
					<fpage>747</fpage>
					<lpage>751</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0004">
				<label>4</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Dutton</surname>
							<given-names>CM</given-names>
						</name>
						<name>
							<surname>Paynton</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Sommer</surname>
							<given-names>SS</given-names>
						</name>
					</person-group>
					<article-title>General method for amplifying regions of high GC content</article-title>
					<source>Nucleic Acids Res</source>
					<year>1993</year>
					<volume>21</volume>
					<issue>12</issue>
					<fpage>2953</fpage>
					<lpage>2954</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0005">
				<label>5</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Musso</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Bocciardi</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>Parodi</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Ravazzolo</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>Ceccherini</surname>
							<given-names>I</given-names>
						</name>
					</person-group>
					<article-title>Betaine, dimethyl sulfoxide, and 7-Deaza-dGTP, a powerful mixture for amplification of GC-rich DNA sequences</article-title>
					<source>J Mol Diagn</source>
					<year>2006</year>
					<volume>8</volume>
					<issue>5</issue>
					<fpage>544</fpage>
					<lpage>550</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0006">
				<label>6</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Wei</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Deng</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Feng</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>Yu</surname>
							<given-names>B</given-names>
						</name>
						<name>
							<surname>Chen</surname>
							<given-names>Y</given-names>
						</name>
					</person-group>
					<article-title>Universal method facilitating the amplification of extremely GC-rich DNA fragments from genomic DNA</article-title>
					<source>Anal Chem</source>
					<year>2010</year>
					<volume>82</volume>
					<issue>14</issue>
					<fpage>6303</fpage>
					<lpage>6307</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0007">
				<label>7</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Henke</surname>
							<given-names>W</given-names>
						</name>
						<name>
							<surname>Herdel</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>Jung</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>Schnorr</surname>
							<given-names>D</given-names>
						</name>
						<name>
							<surname>Loenong</surname>
							<given-names>SA</given-names>
						</name>
					</person-group>
					<article-title>Betaine improves the PCR amplification of GC-rich DNA sequences</article-title>
					<source>Nucleic acid Res</source>
					<year>1997</year>
					<volume>25</volume>
					<issue>19</issue>
					<fpage>3957</fpage>
					<lpage>3958</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0008">
				<label>8</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Jensen</surname>
							<given-names>MA</given-names>
						</name>
						<name>
							<surname>Fukushima</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Davis</surname>
							<given-names>RW</given-names>
						</name>
					</person-group>
					<article-title>DMSO and betaine greatly improve amplification of GC-rich constructs in de novo synthesis</article-title>
					<source>PLoS One</source>
					<year>2010</year>
					<volume>5</volume>
					<issue>6</issue>
					<fpage>e11024</fpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0009">
				<label>9</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Zhang</surname>
							<given-names>Z</given-names>
						</name>
						<name>
							<surname>Yang</surname>
							<given-names>X</given-names>
						</name>
						<name>
							<surname>Meng</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Liu</surname>
							<given-names>F</given-names>
						</name>
						<name>
							<surname>Shen</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Yang</surname>
							<given-names>W</given-names>
						</name>
					</person-group>
					<article-title>Enhanced amplification of GC-rich DNA with two organic reagents</article-title>
					<source>Biotechniques</source>
					<year>2009</year>
					<volume>47</volume>
					<issue>3</issue>
					<fpage>775</fpage>
					<lpage>779</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0010">
				<label>10</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Ferrer-Martinez</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Ruiz-Luzanp</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Chien</surname>
							<given-names>KR</given-names>
						</name>
					</person-group>
					<article-title>Mouse PEP: A novel peroxisomal protein linked to myoblast differentiation and development</article-title>
					<source>Dev Dyn</source>
					<year>2002</year>
					<volume>224</volume>
					<issue>2</issue>
					<fpage>154</fpage>
					<lpage>167</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0011">
				<label>11</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Bostrom</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Wu</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Jedrychowski</surname>
							<given-names>MP</given-names>
						</name>
						<name>
							<surname>Korde</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Ye</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Lo</surname>
							<given-names>JC</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>A PGC-&#x3B1;-dependent myokine that derives brown-fat-like development of white fat and thermogenesis</article-title>
					<source>Nature</source>
					<year>2012</year>
					<volume>148</volume>
					<issue>7382</issue>
					<fpage>463</fpage>
					<lpage>468</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0012">
				<label>12</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Ostadsharif</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Ghaedi</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>Nasr Esfahani</surname>
							<given-names>MH</given-names>
						</name>
						<name>
							<surname>Mojbafan</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Tanhaie</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Karbalaie</surname>
							<given-names>K</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>Retinoic acid increased peroxisomal protein gene expression during neural differentiation</article-title>
					<source>Differentiation</source>
					<year>2011</year>
					<volume>81</volume>
					<issue>2</issue>
					<fpage>127</fpage>
					<lpage>132</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0013">
				<label>13</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Sobocki</surname>
							<given-names>T</given-names>
						</name>
						<name>
							<surname>Jayman</surname>
							<given-names>F</given-names>
						</name>
						<name>
							<surname>Sobocka</surname>
							<given-names>MB</given-names>
						</name>
						<name>
							<surname>Marmur</surname>
							<given-names>JD</given-names>
						</name>
						<name>
							<surname>Banerjee</surname>
							<given-names>P</given-names>
						</name>
					</person-group>
					<article-title>Isolation, Sequencing, and Functional Analysis of the TATA-Less murine ATPase II promoter and structural analysis of the ATPase II gene</article-title>
					<source>Biochem Biophys Acta</source>
					<year>2007</year>
					<volume>1769</volume>
					<issue>1</issue>
					<fpage>61</fpage>
					<lpage>75</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0014">
				<label>14</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Zuker</surname>
							<given-names>M</given-names>
						</name>
					</person-group>
					<article-title>Mfold web server for nucleic acid folding and hybridization prediction</article-title>
					<source>Nucleic Acid Res</source>
					<year>2003</year>
					<volume>31</volume>
					<issue>13</issue>
					<fpage>3406</fpage>
					<lpage>3415</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0015">
				<label>15</label>
				<nlm-citation citation-type="web">
					<comment>
						<ext-link ext-link-type="uri" xlink:href="http://www.med.yale.edu/genetics/ward/tavi/p08.html">http://www.med.yale.edu/genetics/ward/tavi/p08.html</ext-link>.</comment>
				</nlm-citation>
			</ref>
			<ref id="CIT0016">
				<label>16</label>
				<nlm-citation citation-type="web">
					<comment>
						<ext-link ext-link-type="uri" xlink:href="http://www.protocol-online.org/biology-forums/posts/4854.html">http://www.protocol-online.org/biology-forums/posts/4854.html</ext-link>.</comment>
				</nlm-citation>
			</ref>
			<ref id="CIT0017">
				<label>17</label>
				<nlm-citation citation-type="web">
					<comment>
						<ext-link ext-link-type="uri" xlink:href="http://wiki.answers.com/Q/why">http://wiki.answers.com/Q/why</ext-link> is a variable in PCR.</comment></nlm-citation>
			</ref>
			<ref id="CIT0018">
				<label>18</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Brito</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Malta-Vacas</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Carmong</surname>
							<given-names>B</given-names>
						</name>
						<name>
							<surname>Aires</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Costa</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Martins</surname>
							<given-names>AP</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>Polyglycine expansions in eRF3/GS PT1 are associated with gastric cancer susceptibility</article-title>
					<source>Carcinogenesis</source>
					<year>2005</year>
					<volume>26</volume>
					<issue>12</issue>
					<fpage>2046</fpage>
					<lpage>2049</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0019">
				<label>19</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Malta-Vacas</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Chauvin</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Gon&#x00E7;alves</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Nazar&#x00E9;</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Carvalho</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Monteiro</surname>
							<given-names>C</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>eRF3a/GSPT1 12-GGC allele increases the susceptibility for breast cancer development</article-title>
					<source>Oncol Rep</source>
					<year>2009</year>
					<volume>21</volume>
					<issue>6</issue>
					<fpage>1551</fpage>
					<lpage>1558</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0020">
				<label>20</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Malta-Vacas</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Ferreira</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Monteiro</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Brito</surname>
							<given-names>M</given-names>
						</name>
					</person-group>
					<article-title>Differential expression of GSPT1 GGCn alleles in cancer</article-title>
					<source>Cancer Genet Cytogenet</source>
					<year>2009</year>
					<volume>195</volume>
					<issue>2</issue>
					<fpage>132</fpage>
					<lpage>142</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0021">
				<label>21</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Wijesekera</surname>
							<given-names>LC</given-names>
						</name>
						<name>
							<surname>Leigh</surname>
							<given-names>PN</given-names>
						</name>
					</person-group>
					<article-title>Amyotrophic lateral sclerosis</article-title>
					<source>Orphanet J Rare Dis</source>
					<year>2009</year>
					<volume>4</volume>
					<fpage>3</fpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0022">
				<label>22</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Fischbeck</surname>
							<given-names>KH</given-names>
						</name>
						<name>
							<surname>Lieberman</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Bailey</surname>
							<given-names>CK</given-names>
						</name>
						<name>
							<surname>Abel</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Merry</surname>
							<given-names>DE</given-names>
						</name>
					</person-group>
					<article-title>Androgen receptor mutation in Kennedy&#x0027;s disease</article-title>
					<source>Philos Trans R Soc Lond B Biol Sci</source>
					<year>1999</year>
					<volume>354</volume>
					<issue>1386</issue>
					<fpage>1075</fpage>
					<lpage>1078</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0023">
				<label>23</label>
				<nlm-citation citation-type="book">
					<person-group person-group-type="author">
						<name>
							<surname>Chen</surname>
							<given-names>CJ</given-names>
						</name>
						<name>
							<surname>Fischbeck</surname>
							<given-names>KH</given-names>
						</name>
					</person-group>
					<person-group person-group-type="editor">
						<name>
							<surname>Wells</surname>
							<given-names>RD</given-names>
						</name>
						<name>
							<surname>Warren</surname>
							<given-names>ST</given-names>
						</name>
						<name>
							<surname>Sarmiento</surname>
							<given-names>M</given-names>
						</name>
					</person-group>
					<article-title>Clinical aspects and the genetic and molecular biology of Kennedy&#x0027;s disease</article-title>
					<source>Genetic instabilities and hereditary neurological diseases</source>
					<year>2006</year>
					<publisher-loc>Boston</publisher-loc>
					<publisher-name>Academic Press</publisher-name>
					<fpage>211</fpage>
					<lpage>222</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0024">
				<label>24</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Kennedy</surname>
							<given-names>WR</given-names>
						</name>
						<name>
							<surname>Alter</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Sung</surname>
							<given-names>JH</given-names>
						</name>
					</person-group>
					<article-title>Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait</article-title>
					<source>Neurology</source>
					<year>1968</year>
					<volume>18</volume>
					<issue>7</issue>
					<fpage>671</fpage>
					<lpage>680</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0025">
				<label>25</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>La Spada</surname>
							<given-names>AR</given-names>
						</name>
						<name>
							<surname>Wilson</surname>
							<given-names>EM</given-names>
						</name>
						<name>
							<surname>Lubahn</surname>
							<given-names>DB</given-names>
						</name>
						<name>
							<surname>Harding</surname>
							<given-names>AE</given-names>
						</name>
						<name>
							<surname>Fischbeck</surname>
							<given-names>KH</given-names>
						</name>
					</person-group>
					<article-title>Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy</article-title>
					<source>Nature</source>
					<year>1991</year>
					<volume>352</volume>
					<issue>6330</issue>
					<fpage>77</fpage>
					<lpage>79</lpage>
				</nlm-citation>
			</ref>
		</ref-list>
	</back>
</article>
